SCHEMBL851894

SCHEMBL851894

C=CC/[C]=C/CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7034319 1.00
SCHEMBL10880422 0.78
SCHEMBL3341875 0.74
SCHEMBL8364896 0.73
SCHEMBL1888612 0.72 TSHR (0.52)
SCHEMBL14855802 0.72
SCHEMBL6347396 0.71 TSHR (0.56)
Propane SCHEMBL18783169 0.69
SCHEMBL759062 0.69
SCHEMBL4663999 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226313-A1 CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF SEAGEN INC. 2024-07-11 US disclosed
US-12029736-B2 Camptothecin derivatives and conjugates thereof MEDIBOSTON LIMITED (HK) 2024-07-09 US disclosed
US-20240199534-A1 CYCLOPROPANE ANALOGUES OF N-(TRANS-4-HYDROXYCYCLOHEXYL)-6-PHENYLHEXANAMIDE AND RELATED COMPOUNDS DORN, GERALD W., II, DR. 2024-06-20 US disclosed
WO-2024107014-A1 ANTI-BASAL CELL ADHESION MOLECULE ANTIBODY-DRUG CONJUGATE GENOME AND COMPANY (KR) 2024-05-23 WO disclosed
US-20240108744-A1 AURISTATIN DERIVATIVES AND CONJUGATES THEREOF FORTVITA BIOLOGICS LIMITED (CN) 2024-04-04 US disclosed
WO-2024023735-A1 AURISTATIN DERIVATIVES AND CONJUGATES THEREOF MEDIBOSTON LIMITED (CN) 2024-02-01 WO disclosed
EP-4297797-A2 ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF MediBoston Limited (HK) 2024-01-03 EP disclosed
US-20230381321-A1 CAMPTOTHECIN CONJUGATES SEAGEN INC. 2023-11-30 US disclosed
WO-2023200144-A1 INDIUM COMPOUND, INDIUM-CONTAINING THIN FILM DEPOSITION COMPOSITION COMPRISING SAME, AND INDIUM-CONTAINING THIN FILM MANUFACTURING METHOD (주)디엔에프 2023-10-19 WO disclosed
WO-2023195691-A1 SILICON-BEARING ENCAPSULATION FILM COMPOSITION INCLUDING SILAZANE COMPOUND AND METHOD FOR MANUFACTURING SILICON-BEARING ENCAPSULATION FILM USING SAME (주)디엔에프 2023-10-12 WO disclosed
EP-1583763-A1 BENZOAZOLYPIPERAZINE DERIVATIVES HAVING MGLUR1- AND MGLUR5-ANTAGONISTIC ACTIVITY Euro-Celtique S.A. (LU) 2005-10-12 EP disclosed
EP-1556354-A2 THERAPEUTIC PIPERAZINE DERIVATES USEFUL FOR TREATING PAIN Euroceltique S.A. (LU) 2005-07-27 EP disclosed
EP-1534726-A2 NUCLEOSIDE COMPOUNDS AND THEIR USE FOR TREATING CANCER AND DISEASES ASSOCIATED WITH SOMATIC MUTATIONS PTC Therapeutics, Inc. (US) 2005-06-01 EP disclosed
EP-1519751-A2 COMPOSITIONS COMPRISING PANTHETINE FOR THE TREATMENT OF DYSLIPIDEMIA Esperion Therapeutics Inc. (US) 2005-04-06 EP disclosed
WO-2005012287-A1 THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN EURO-CELTIQUE S.A. (LU) 2005-02-10 WO disclosed
WO-2004058754-A1 BENZOAZOLYPIPERAZINE DERIVATIVES HAVING MGLUR1- AND MGLUR5-ANTAGONISTIC ACTIVITY EURO-CELTIQUE S.A. (LU) 2004-07-15 WO disclosed
WO-2004009609-A2 NUCLEOSIDE COMPOUNDS AND THEIR USE FOR TREATING CANCER AND DISEASES ASSOCIATED WITH SOMATIC MUTATIONS PTC THERAPEUTICS, INC. (US) 2004-01-29 WO disclosed
WO-2004004774-A2 COMPOSITIONS COMPRISING PANTHETINE FOR THE TREATMENT OF DYSLIPIDEMIA ESPERION THERAPEUTICS, INC. (US) 2004-01-15 WO disclosed
WO-2004002983-A2 THERAPEUTIC PIPERAZINE DERIVATIVES USEFUL FOR TREATING PAIN EURO-CELTIQUE, S.A. (LU) 2004-01-08 WO disclosed
EP-1286190-A1 OPTICAL CONNECTION COMPONENT TOMOEGAWA PAPER CO. LTD. (JP) 2003-02-26 EP disclosed